rabbit anti pret py905 antibodies Search Results


94
Cell Signaling Technology Inc rabbit anti pret py905 antibodies
Rabbit Anti Pret Py905 Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+pret+py905+antibodies/Phospho-Ret+(Tyr905)+Antibody/bio_rxiv__2021__05__19__444897-178-11-16
Average 94 stars, based on 1 article reviews
rabbit anti pret py905 antibodies - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse monoclonal anti ret antibodies
Mouse Monoclonal Anti Ret Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+pret+py905+antibodies/Ret+Antibody/bio_rxiv__2021__05__19__444897-178-0-6
Average 93 stars, based on 1 article reviews
mouse monoclonal anti ret antibodies - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology phosphorylated erk
Phosphorylation of multiple RTKs in lung cancer cells with MET amplification. ( A ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence (control) or presence of PHA-665752 (500 n M ). Cell lysates were prepared and incubated with an RTK array for determination of the phosphorylation status of each enzyme. Each RTK is spotted in duplicate, and the pairs of dots in each corner of the array are positive controls. The numbered pairs of dots correspond to the indicated <t>phosphorylated</t> (p-) RTKs. ( B ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence or presence of PHA-665752 (PHA, 500 n M ), gefitinib (1 μ M ), lapatinib (1 μ M ), or vandetanib (1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to phosphorylated or total forms of MET, EGFR, HER2, HER3, RET, AKT, <t>ERK,</t> or STAT3 or with those to β -actin (loading control). ( C ) The indicated cell lines were deprived of serum for 24 h and then incubated for 2 h in the absence (Con) or presence of gefitinib (Gef, 1 μ M ), lapatinib (Lap, 1 μ M ), or vandetanib (Van, 1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to the indicated proteins.
Phosphorylated Erk, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+pret+py905+antibodies/p-ERK+Antibody/pmc03171021-19-67-71
Average 96 stars, based on 1 article reviews
phosphorylated erk - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc anti ret
Phosphorylation of multiple RTKs in lung cancer cells with MET amplification. ( A ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence (control) or presence of PHA-665752 (500 n M ). Cell lysates were prepared and incubated with an RTK array for determination of the phosphorylation status of each enzyme. Each RTK is spotted in duplicate, and the pairs of dots in each corner of the array are positive controls. The numbered pairs of dots correspond to the indicated <t>phosphorylated</t> (p-) RTKs. ( B ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence or presence of PHA-665752 (PHA, 500 n M ), gefitinib (1 μ M ), lapatinib (1 μ M ), or vandetanib (1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to phosphorylated or total forms of MET, EGFR, HER2, HER3, RET, AKT, <t>ERK,</t> or STAT3 or with those to β -actin (loading control). ( C ) The indicated cell lines were deprived of serum for 24 h and then incubated for 2 h in the absence (Con) or presence of gefitinib (Gef, 1 μ M ), lapatinib (Lap, 1 μ M ), or vandetanib (Van, 1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to the indicated proteins.
Anti Ret, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+pret+py905+antibodies/Ret+Antibody/pmc03954818-45-103-104
Average 93 stars, based on 1 article reviews
anti ret - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc akt
Phosphorylation of multiple RTKs in lung cancer cells with MET amplification. ( A ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence (control) or presence of PHA-665752 (500 n M ). Cell lysates were prepared and incubated with an RTK array for determination of the phosphorylation status of each enzyme. Each RTK is spotted in duplicate, and the pairs of dots in each corner of the array are positive controls. The numbered pairs of dots correspond to the <t>indicated</t> <t>phosphorylated</t> (p-) RTKs. ( B ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence or presence of PHA-665752 (PHA, 500 n M ), gefitinib (1 μ M ), lapatinib (1 μ M ), or vandetanib (1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to phosphorylated or total forms of MET, EGFR, HER2, HER3, RET, <t>AKT,</t> ERK, or STAT3 or with those to β -actin (loading control). ( C ) The indicated cell lines were deprived of serum for 24 h and then incubated for 2 h in the absence (Con) or presence of gefitinib (Gef, 1 μ M ), lapatinib (Lap, 1 μ M ), or vandetanib (Van, 1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to the indicated proteins.
Akt, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+pret+py905+antibodies/Akt+Antibody/pmc03171021-19-25-49
Average 99 stars, based on 1 article reviews
akt - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti pakt s473
Phosphorylation of multiple RTKs in lung cancer cells with MET amplification. ( A ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence (control) or presence of PHA-665752 (500 n M ). Cell lysates were prepared and incubated with an RTK array for determination of the phosphorylation status of each enzyme. Each RTK is spotted in duplicate, and the pairs of dots in each corner of the array are positive controls. The numbered pairs of dots correspond to the <t>indicated</t> <t>phosphorylated</t> (p-) RTKs. ( B ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence or presence of PHA-665752 (PHA, 500 n M ), gefitinib (1 μ M ), lapatinib (1 μ M ), or vandetanib (1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to phosphorylated or total forms of MET, EGFR, HER2, HER3, RET, <t>AKT,</t> ERK, or STAT3 or with those to β -actin (loading control). ( C ) The indicated cell lines were deprived of serum for 24 h and then incubated for 2 h in the absence (Con) or presence of gefitinib (Gef, 1 μ M ), lapatinib (Lap, 1 μ M ), or vandetanib (Van, 1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to the indicated proteins.
Anti Pakt S473, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+pret+py905+antibodies/Phospho-Akt+(Ser473)+Antibody/pmc03954818-45-113-115
Average 99 stars, based on 1 article reviews
anti pakt s473 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

Image Search Results


Phosphorylation of multiple RTKs in lung cancer cells with MET amplification. ( A ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence (control) or presence of PHA-665752 (500 n M ). Cell lysates were prepared and incubated with an RTK array for determination of the phosphorylation status of each enzyme. Each RTK is spotted in duplicate, and the pairs of dots in each corner of the array are positive controls. The numbered pairs of dots correspond to the indicated phosphorylated (p-) RTKs. ( B ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence or presence of PHA-665752 (PHA, 500 n M ), gefitinib (1 μ M ), lapatinib (1 μ M ), or vandetanib (1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to phosphorylated or total forms of MET, EGFR, HER2, HER3, RET, AKT, ERK, or STAT3 or with those to β -actin (loading control). ( C ) The indicated cell lines were deprived of serum for 24 h and then incubated for 2 h in the absence (Con) or presence of gefitinib (Gef, 1 μ M ), lapatinib (Lap, 1 μ M ), or vandetanib (Van, 1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to the indicated proteins.

Journal: British Journal of Cancer

Article Title: Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification

doi: 10.1038/bjc.2011.322

Figure Lengend Snippet: Phosphorylation of multiple RTKs in lung cancer cells with MET amplification. ( A ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence (control) or presence of PHA-665752 (500 n M ). Cell lysates were prepared and incubated with an RTK array for determination of the phosphorylation status of each enzyme. Each RTK is spotted in duplicate, and the pairs of dots in each corner of the array are positive controls. The numbered pairs of dots correspond to the indicated phosphorylated (p-) RTKs. ( B ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence or presence of PHA-665752 (PHA, 500 n M ), gefitinib (1 μ M ), lapatinib (1 μ M ), or vandetanib (1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to phosphorylated or total forms of MET, EGFR, HER2, HER3, RET, AKT, ERK, or STAT3 or with those to β -actin (loading control). ( C ) The indicated cell lines were deprived of serum for 24 h and then incubated for 2 h in the absence (Con) or presence of gefitinib (Gef, 1 μ M ), lapatinib (Lap, 1 μ M ), or vandetanib (Van, 1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to the indicated proteins.

Article Snippet: Rabbit polyclonal antibodies to phosphorylated human MET (pY1234/pY1235), to phosphorylated EGFR (pY1068), to phosphorylated HER2 (pY1221), to phosphorylated HER3 (pY1289), to phosphorylated RET (pY905), to AKT, to phosphorylated AKT, to signal transducer and activator of transcription 3 (STAT3), to phosphorylated STAT3, and to poly(ADP-ribose) polymerase (PARP) were obtained from Cell Signaling Technology (Danvers, MA, USA); those to HER3, to RET, to extracellular signal-regulated kinase (ERK), and to phosphorylated ERK were from Santa Cruz Biotechnology (Santa Cruz, CA, USA); those to MET were from Zymed (South San Francisco, CA, USA); those to HER2 were from Millipore (Billerica, MA, USA); and those to β -actin were from Sigma.

Techniques: Phospho-proteomics, Amplification, Incubation, Control, Western Blot

Phosphorylation of multiple RTKs in lung cancer cells with MET amplification. ( A ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence (control) or presence of PHA-665752 (500 n M ). Cell lysates were prepared and incubated with an RTK array for determination of the phosphorylation status of each enzyme. Each RTK is spotted in duplicate, and the pairs of dots in each corner of the array are positive controls. The numbered pairs of dots correspond to the indicated phosphorylated (p-) RTKs. ( B ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence or presence of PHA-665752 (PHA, 500 n M ), gefitinib (1 μ M ), lapatinib (1 μ M ), or vandetanib (1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to phosphorylated or total forms of MET, EGFR, HER2, HER3, RET, AKT, ERK, or STAT3 or with those to β -actin (loading control). ( C ) The indicated cell lines were deprived of serum for 24 h and then incubated for 2 h in the absence (Con) or presence of gefitinib (Gef, 1 μ M ), lapatinib (Lap, 1 μ M ), or vandetanib (Van, 1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to the indicated proteins.

Journal: British Journal of Cancer

Article Title: Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification

doi: 10.1038/bjc.2011.322

Figure Lengend Snippet: Phosphorylation of multiple RTKs in lung cancer cells with MET amplification. ( A ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence (control) or presence of PHA-665752 (500 n M ). Cell lysates were prepared and incubated with an RTK array for determination of the phosphorylation status of each enzyme. Each RTK is spotted in duplicate, and the pairs of dots in each corner of the array are positive controls. The numbered pairs of dots correspond to the indicated phosphorylated (p-) RTKs. ( B ) EBC-1 and H1993 cells were deprived of serum for 24 h and then incubated for 2 h in the absence or presence of PHA-665752 (PHA, 500 n M ), gefitinib (1 μ M ), lapatinib (1 μ M ), or vandetanib (1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to phosphorylated or total forms of MET, EGFR, HER2, HER3, RET, AKT, ERK, or STAT3 or with those to β -actin (loading control). ( C ) The indicated cell lines were deprived of serum for 24 h and then incubated for 2 h in the absence (Con) or presence of gefitinib (Gef, 1 μ M ), lapatinib (Lap, 1 μ M ), or vandetanib (Van, 1 μ M ), after which cell lysates were subjected to immunoblot analysis with antibodies to the indicated proteins.

Article Snippet: Rabbit polyclonal antibodies to phosphorylated human MET (pY1234/pY1235), to phosphorylated EGFR (pY1068), to phosphorylated HER2 (pY1221), to phosphorylated HER3 (pY1289), to phosphorylated RET (pY905), to AKT, to phosphorylated AKT, to signal transducer and activator of transcription 3 (STAT3), to phosphorylated STAT3, and to poly(ADP-ribose) polymerase (PARP) were obtained from Cell Signaling Technology (Danvers, MA, USA); those to HER3, to RET, to extracellular signal-regulated kinase (ERK), and to phosphorylated ERK were from Santa Cruz Biotechnology (Santa Cruz, CA, USA); those to MET were from Zymed (South San Francisco, CA, USA); those to HER2 were from Millipore (Billerica, MA, USA); and those to β -actin were from Sigma.

Techniques: Phospho-proteomics, Amplification, Incubation, Control, Western Blot